Profile_bird

Hey there! DrAnasYounes is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving DrAnasYounes's tweets.

Already using Twitter
from your phone? Click here.

DrAnasYounes

  1. ASH 2009 Reports: Long Term follow up of Bexxar Therapy in Rituximab-Refractory Lymphoma http://bit.ly/087Lc8L about 3 hours ago from Facebook
  2. Become a fan and ask questions: On December 8, after the conclusion of the annual meeting of the American Society... http://bit.ly/50a27s about 4 hours ago from Facebook
  3. On December 8, I will be taking questions on twitter regarding new data presented at the ASH meeting, answers on my FB http://bit.ly/Uo9Yh about 4 hours ago from TweetDeck
  4. ASH 2009 Reports: Rationale or therapeutic targeting of Tak-1 in mantle cell lymphoma http://bit.ly/7Agp4X about 4 hours ago from TweetDeck
  5. RT @teamoncology: Just did practice presentaion for San Antonio Breast Cancer to Dept of Breat Med Oncology, M. D. Anderson Cancer ctr about 13 hours ago from TweetDeck
  6. RT @DrAnasYounes: ASH 2009 Reports: Rationale or therapeutic targeting of Tak-1 http://bit.ly/7Agp4X about 14 hours ago from TweetDeck
  7. ASH 2009 Reports: Rationale or therapeutic targeting of Tak-1 http://bit.ly/07IqXdG about 14 hours ago from Facebook
  8. Very exciting new data on new promising lymphoma therapy to be presented at the ASH meeting in December. http://bit.ly/273lo6 about 14 hours ago from TweetDeck
  9. ASH 2009 Reports: Rituximab Therapy Decreases the Benefit of Influenza Vaccine http://bit.ly/6XWcRQ 6:42 AM Nov 23rd from TweetDeck
  10. Finally, NYT get the real story behind the new guidelines RT @nytimeshealth: Behind Cancer Guidelines, Quest for Data http://bit.ly/88Zp4u 9:02 PM Nov 22nd from TweetDeck
  11. Finally, Gina Kolata of the NYT present a balanced story on the new mammogram... http://bit.ly/57v6rH 8:57 PM Nov 22nd from Facebook
  12. We are enrolling patients on this study RT @cancertrials_: phase ii r-abvd vs abvd 4 advanced stage hodgkin lymphoma http://bit.ly/5WrBTn 8:45 PM Nov 22nd from TweetDeck
  13. M.D. Anderson Doctor in... http://bit.ly/5h53VH 8:12 AM Nov 22nd from Facebook
  14. RT @DrAnasYounes: Get a Mammogram. No Don’t.... http://bit.ly/5T3cat 6:11 AM Nov 22nd from TweetDeck
  15. Get a Mammogram. No Don’t.... http://bit.ly/5T3cat 7:07 PM Nov 21st from Facebook
  16. @MedGeek No. But ASH will record all the presentations at the meeting. 4:06 PM Nov 21st from TweetDeck in reply to MedGeek
  17. At MDAnderson hematologic malignancies retreat. I will be talking on HDAC inhibitors in lymphoma 2:24 PM Nov 21st from Echofon
  18. RT @Rndubois: 403 Texas Cancer Prevention and Research Institute Proposals are still in contention for funding: http://tinyurl.com/yh38357 8:47 AM Nov 21st from TweetDeck
  19. RT @cancer_news: Increase in Oral Cancer Drugs Raises Thorny Issues for Oncology Practices - http://is.gd/50nyy 6:56 AM Nov 21st from Echofon
  20. Thanks for the RTs @riggrl @drsteventucker #Google #hcsm@CarmenBPhillips @palmdoc @DonnaReinbolt @LRF_Houston @MarionSwan #FF #healthcare 3:01 PM Nov 20th from TweetDeck
  • Name Anas Younes, M.D.
  • Location Houston, Texas
  • Web http://bit.ly/DxQLm
  • Bio Lymphoma expert and Professor of Medicine at M.D.Anderson Cancer Ctr. I tweet on medicine, cancer & health
161 Following 814 Followers 44 Listed
LRF Houston Bryan Vartabedian LymphomaMatters Ves Dimov, M.D. Heidi Adams Mark Browne Cancer Research UK Can Cancer Society BBC Click OncologySTAT The Twitting Doctors Doctors.net.uk Cancer Info oncoletter AstraZeneca Irene Tato Guardian Science New Scientist Times Science ecancer Reuters Health Cell CellPress Wellcome Trust NYTimes The Lede Associated Press Annals of Oncology Medscape Oncology The Guardian Newsweek herald_tribune The Daily Telegraph Bertalan Meskó, MD KentBottles Sarah Weinman Danny Sands docrkp